UK markets close in 5 hours 1 minute

RepliCel Life Sciences Inc. (RP.V)

TSXV - TSXV Real-time price. Currency in CAD
Add to watchlist
0.05500.0000 (0.00%)
At close: 03:56PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-69.287
-743.228
-4,073
-1,580
Depreciation & amortisation
1.411
0.839
1.148
1.574
Stock-based compensation
282.43
69.056
471.756
3.397
Change in working capital
-388.373
267.546
-324.236
915.971
Other working capital
-1,992
-1,409
-2,514
-765.206
Other non-cash items
-2,454
-1,591
419.231
-349.634
Net cash provided by operating activities
-1,992
-1,409
-2,514
-765.206
Cash flows from investing activities
Sales/maturities of investments
-
0
0
11.5
Net cash used for investing activities
-
0
0
11.5
Cash flows from financing activities
Common stock issued
2,196
1,601
0
656.84
Other financing activities
-
-
2,699
-
Net cash used provided by (used for) financing activities
1,929
1,601
2,701
764.139
Net change in cash
-62.83
191.837
186.825
10.433
Cash at beginning of period
78.06
221.188
34.363
23.93
Cash at end of period
15.23
413.025
221.188
34.363
Free cash flow
Operating cash flow
-1,992
-1,409
-2,514
-765.206
Free cash flow
-1,992
-1,409
-2,514
-765.206